C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
第一作者:
Baihua,Xu
第一单位:
Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu, Sichuan, PR China. baihuaxu@egretpharma.com
作者:
医学主题词
糖尿病, 2型(Diabetes Mellitus, Type 2);葡糖苷类(Glucosides);人类(Humans);降血糖药(Hypoglycemic Agents);钠-葡萄糖转运体1(Sodium-Glucose Transporter 1);钠-葡萄糖转运体2(Sodium-Glucose Transporter 2);构效关系(Structure-Activity Relationship)
DOI
10.1016/j.bmcl.2011.06.032
PMID
21737266
发布时间
2018-12-01
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



